Cargando…
Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma
Deregulated mRNA translation has been implicated in disease development and in part is controlled by a eukaryotic initiation complex eIF4F (composed of eIF4E, eIF4G and eIF4A). We demonstrate here that the cap bound fraction from lymphoma cells was enriched with eIF4G and eIF4E indicating that lymph...
Autores principales: | Demosthenous, Christos, Han, Jing Jing, Stenson, Mary J., Maurer, Matthew J., Wellik, Linda E., Link, Brian, Hege, Kristen, Dogan, Ahmet, Sotomayor, Eduardo, Witzig, Thomas, Gupta, Mamta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496233/ https://www.ncbi.nlm.nih.gov/pubmed/25839159 |
Ejemplares similares
-
eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage
por: Ma, Shijie, et al.
Publicado: (2022) -
Temporal and spatial regulation of translation in the mammalian oocyte via the mTOR–eIF4F pathway
por: Susor, Andrej, et al.
Publicado: (2015) -
The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
por: Driva, Tatiana S., et al.
Publicado: (2022) -
Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma
por: Demosthenous, Christos, et al.
Publicado: (2015) -
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
por: Abeykoon, Jithma P., et al.
Publicado: (2019)